Life with hereditary angioedema: Then and now

Postgraduate Medicine

Volumn 124, Issue 1, 2012, Pages 144-151

  Lane, Charles Joseph ^a   Andrew Grant, J ^b   Dougherty III , Dane ^b  

^a Allergy Partners of Lynchburg   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Angioedema; Bradykinin; C1 esterase inhibitor; Complement; Hereditary angioedema; Pedigree

Indexed keywords

ANDROGEN; BRADYKININ; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE;

ABDOMINAL PAIN; ABDOMINAL SWELLING; ANGIONEUROTIC EDEMA; ARTICLE; FAMILY HISTORY; FOOT EDEMA; GENITAL EDEMA; HUMAN; INHERITANCE; LARYNX EDEMA; LEG EDEMA; MORTALITY; PATHOPHYSIOLOGY; SWELLING; SYMPTOM;

ADULT; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MALE; MIDDLE AGED;

EID: 84856874978     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.01.2527     Document Type: Article

References (24)

1. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31(5):407-414.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596-615.
3. Davis AE 3rd. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol. 1988;6:595-628.
4. Kaplan A. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010;126(5):918-925.
5. Zuraw B. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.
6. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-274.
7. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84(5):580-593.
8. Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 suppl):S51-S131.
9. Lunn ML, Santos CB, Craig TJ. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Ann Allergy Asthma Immunol. 2010;104(3):211-214.
10. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379-394.
11. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26(4):653-658.
12. Quincke H. ÜberakutesumschreibnesHautödem. MonatschrPraktDermatol. 1882;1:129-131.
13. Strübing P. Ueberacutes (angioneurotisches) Oedema. Ztschr F Klin Med. 1885;9:381-396.
14. Osler W. Hereditary angio-neurotic oedema. Am J Med Sci. 1888;95(2):362-367.
15. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase. Am J Med. 1963;35:37-44.
16. Ensor C. Some cases illustrating the influence of hereditary angeioneurotic oedema. Guys Hosp Rep. 1904;58:111-120.
17. Crowder JR, Crowder TR. Five generations of angioneurotic edema. Arch Int Med. 1917;20(6):840-852.
18. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101:619-627.
19. Landerman NS. Hereditary angioneurotic edema, I: case reports and review of the literature. J Allergy. 1962;33:316-329.
20. Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci. 1982;284:2-9.
21. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc. 2000;75(4):349-354.
22. Spaulding WB. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med. 1960;53:739-745.
23. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. N Engl J Med. 1976;295(26):1444-1448.
24. Zuraw B, Davis A, Castaldo A. Tolerability and efficacy of attenuated anabolic androgen therapy in 731 HAE patients. Presented at: 6th European C1 INH Deficiency Workshop; May 22-24, 2009; Budapest, Hungary.